MARLA KUSHNER: Open Payments
NPI 1538119268 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 18 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $149 |
| Braeburn Inc. | 5 | $95 |
| Indivior Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $44 |
| ABBVIE INC. | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: VIVITROL, BRIXADI, SUBLOCADE, Ozempic, LINZESS, INSPIRE, Xelstrym, XIFAXAN.
Industry payments across IL — which companies pay providers there.
